Intelligence · Clinical Development
Pipeline search results
Programs matching “antibody” across our ClinicalTrials.gov index — phase, modality, sponsor, and trial IDs.
Quick answer
Showing 75 pipeline programs matching "antibody" from NovaPharmaNews Clinical Development Intelligence — phase, modality, sponsor, and ClinicalTrials.gov trial IDs.
Refine search
Search results
-
anti-BCMA/CD3 bispecific antibody
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Multiple Myeloma
1 trial -
recombinant humanized anti-CD25 monoclonal antibody
The First People's Hospital of Lianyungang
Transfusion Dependent Thalassemia
1 trial -
124I-labeled monoclonal antibody Mu 11-1F4
BRIGHT MINDS BIOSCIENCES INC.
AL Amyloidosis
1 trial -
ACTINIUM-225-LABELED HUMANIZED ANTI-CD33 MONOCLONAL ANTIBODY HuM195
Actinium Pharmaceuticals
Leukemia
1 trial -
Anti-CD20 monoclonal antibody and the BTK inhibitor
The First People's Hospital of Lianyungang
Anti-CD20 Monoclonal Antibody
1 trial -
Anti-Macrophage Migration Inhibitory Factor (Anti-MIF) Antibody
Takeda
Systemic Lupus Erythematosus
1 trial -
Anti-Macrophage Migration Inhibitory Factor (Anti-MIF) Antibody
Takeda
Metastatic Adenocarcinoma of the Colon or Rectum
1 trial -
Anti-SEMA4D Monoclonal Antibody VX15/2503
VACCINEX, INC.
Colon Carcinoma Metastatic in the Liver
1 trial -
Anti-SEMA4D Monoclonal Antibody VX15/2503
VACCINEX, INC.
Metastatic Melanoma
1 trial -
Anti-human CCL24 monoclonal antibody (CM-101)
Chemomab Therapeutics
Healthy
1 trial -
Anti-human CCL24 monoclonal antibody (CM-101) - Part One
Chemomab Therapeutics
Nonalcoholic Fatty Liver Disease
1 trial -
Antibody UB-421
United Therapeutics Europe Ltd
HIV-1 Infection in Adults (Asymptomatic)
1 trial -
BCSW-LDP+CDP1-Ⅰ-01
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Advanced Malignant Tumor
1 trial -
CM336 (BCMA/CD3 bispecific antibody)
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Relapsed Refractory Multiple Myeloma (RRMM)
1 trial -
Casirivimab and Imdevimab Antibody Cocktail
Regeneron UK Limited
COVID-19
1 trial -
FT819
Zafatek
Antineutrophilic Cytoplasmic Antibody (ANCA)- Associated Vasculitis (AAV)
1 trial -
Humanized TNFα monoclonal antibody
Sunshine Guojian Pharmaceutical (Shanghai) Co.,
Rheumatoid Arthritis
1 trial -
Humanized anti-CD117 Monoclonal Antibody (JSP191)
Jasper Therapeutics
MYELODYSPLASTIC SYNDROME; MDS
1 trial -
INBRX-105 - PDL1x41BB antibody
Inhibrx Biosciences
Metastatic Solid Tumors
1 trial -
Recombinant Humanized Anti-IL-36R Monoclonal antibody and Placebo
Shanghai University of Traditional Chinese Medicine
Healthy
1 trial -
anti-EGFR monoclonal antibody
Dragonboat Biopharmaceutical Company Limited
Healthy Volunteers
1 trial -
monoclonal antibody M-T412
Ultragenyx UK Limited
Multiple Sclerosis
1 trial -
20220159
Amgen
Antineutrophil cytoplasmic antibody-associated vasculitis (AAV)
1 trial -
CM-336 BCMA/CD3 bispecific antibody
Xiyuan Hospital of China Academy of Chinese Medical Sciences
AL Amyloidosis
1 trial
Frequently asked questions
What is the Clinical Development Intelligence Platform?
It is NovaPharmaNews pipeline intelligence hub covering 20,548 clinical development programs — not just a directory. It includes phase distribution dashboards, therapeutic area overviews, NDA/BLA watchlists, upcoming readouts, company pipeline rankings, competitive landscape maps, and personalized watchlists.
How does this compare to Evaluate Pharma or Citeline?
Like Evaluate Pharma and Citeline Trialtrove, we index ClinicalTrials.gov programs by sponsor, phase, and indication. Our platform adds cross-links to NovaPharmaNews company profiles, drug INN pages, patents, and congress readout calendars — improving crawl depth and reducing orphan program pages.
Where does pipeline data come from?
Program records derive from ClinicalTrials.gov and link to sponsor company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment decisions. See our data sources page for attribution.
Can I follow a company or program for updates?
Yes — use the watchlist forms on this page to follow sponsors, individual programs, disease clusters, or therapeutic areas. Alerts use the same subscription infrastructure as our events intelligence hub.